Combined high‐grade neuroendocrine carcinoma of the lung: Clinicopathological and immunohistochemical study of 34 surgically resected cases
- 29 January 2014
- journal article
- Published by Wiley in Pathology International
- Vol. 64 (1) , 28-33
Abstract
To understand the pathogenesis of high‐grade neuroendocrine carcinoma (HGNEC), we examined the histopathology and immunoreactivity against adenocarcinoma (AD), squamous cell carcinoma (SQ), and neuroendocrine markers in 34 cases with combined HGNEC. The 5 year overall survival rates of patients with combined small cell carcinoma (SCC) (n = 9) and combined large cell neuroendocrine carcinoma (LCNEC) (n = 25) were 33% and 75%, respectively (P = 0.011). Most of the patients were male (94%), smokers (94%), and had tumors located in the peripheral (94%) and upper lobe (65%) of the lung. Histopathologically, non‐HGNEC components were predominantly ADs (65%) followed by SQs (26%). In combined HGNEC and AD, a lepidic AD component was found in 12 cases (48%). For the HGNEC components of combined HGNEC and AD, the incidence of positivity of thyroid transcription factor‐1 (TTF‐1) (8G7G3/1) and TTF1 (SPT24) were 64% and 91%, respectively. For HGNEC components of combined HGNEC and SQ, the incidence of positivity of 34βE12 and p63 were 22% and 11%, respectively. In conclusion, 48% of combined HGNEC and AD cases had a lepidic AD component, suggesting that HGNEC can develop in association with pre‐existing AD. AD markers, but not SQ markers, were frequently retained through development of the HGNEC component.Keywords
This publication has 13 references indexed in Scilit:
- Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002Journal of Thoracic Oncology, 2010
- Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular dataVirchows Archiv, 2007
- Neuroendocrine Neoplasms of the Lung: A Prognostic SpectrumJournal of Clinical Oncology, 2006
- 34βE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinomaHistopathology, 2003
- Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significanceEuropean Journal of Cardio-Thoracic Surgery, 2002
- Small Cell Lung Carcinoma (SCLC)American Journal of Surgical Pathology, 2002
- Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty-seven casesThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34βE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lungHuman Pathology, 2001
- Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomasHuman Pathology, 2000
- Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sitesHistopathology, 2000